151 related articles for article (PubMed ID: 38167321)
21. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
Zuiverloon TC; Beukers W; van der Keur KA; Munoz JR; Bangma CH; Lingsma HF; Eijkemans MJ; Schouten JP; Zwarthoff EC
BJU Int; 2012 Mar; 109(6):941-8. PubMed ID: 21756281
[TBL] [Abstract][Full Text] [Related]
22. IL-8 as a urinary biomarker for the detection of bladder cancer.
Urquidi V; Chang M; Dai Y; Kim J; Wolfson ED; Goodison S; Rosser CJ
BMC Urol; 2012 May; 12():12. PubMed ID: 22559832
[TBL] [Abstract][Full Text] [Related]
23. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
Valenberg FJPV; Hiar AM; Wallace E; Bridge JA; Mayne DJ; Beqaj S; Sexton WJ; Lotan Y; Weizer AZ; Jansz GK; Stenzl A; Danella JF; Shepard B; Cline KJ; Williams MB; Montgomery S; David RD; Harris R; Klein EW; Bradford TJ; Wolk FN; Westenfelder KR; Trainer AF; Richardson TA; Egerdie RB; Goldfarb B; Zadra JA; Ge S; Zhao S; Simon IM; Campbell SA; Rhees B; Bates MP; Higuchi RG; Witjes JA
Eur Urol; 2019 May; 75(5):853-860. PubMed ID: 30553612
[TBL] [Abstract][Full Text] [Related]
24. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva.
Arellano-Garcia ME; Hu S; Wang J; Henson B; Zhou H; Chia D; Wong DT
Oral Dis; 2008 Nov; 14(8):705-12. PubMed ID: 19193200
[TBL] [Abstract][Full Text] [Related]
25. Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro.
Codorean E; Nichita C; Albulescu L; Răducan E; Popescu ID; Lonită AC; Albulescu R
Roum Arch Microbiol Immunol; 2010; 69(1):13-9. PubMed ID: 21053779
[TBL] [Abstract][Full Text] [Related]
26. Incorporating Aptamers in the Multiple Analyte Profiling Assays (xMAP): Detection of C-Reactive Protein.
Bernard ED; Nguyen KC; DeRosa MC; Tayabali AF; Aranda-Rodriguez R
Methods Mol Biol; 2017; 1575():303-322. PubMed ID: 28255889
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
[TBL] [Abstract][Full Text] [Related]
28. MAGPIX and FLEXMAP 3D Luminex platforms for direct detection of miR-122-5p through dynamic chemical labelling.
Marín-Romero A; Regele V; Kolanovic D; Hofner M; Díaz-Mochón JJ; Nöhammer C; Pernagallo S
Analyst; 2023 Nov; 148(22):5658-5666. PubMed ID: 37807710
[TBL] [Abstract][Full Text] [Related]
29. Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers - comparison of ELISA and microsphere-based multiplexed immunoassay.
Kornacker M; Roth A; Christensen O; Krätzschmar J; Wensing G
Clin Chem Lab Med; 2008; 46(9):1256-64. PubMed ID: 18681833
[TBL] [Abstract][Full Text] [Related]
30. A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX).
Mazhari R; Brewster J; Fong R; Bourke C; Liu ZSJ; Takashima E; Tsuboi T; Tham WH; Harbers M; Chitnis C; Healer J; Ome-Kaius M; Sattabongkot J; Kazura J; Robinson LJ; King C; Mueller I; Longley RJ
PLoS One; 2020; 15(12):e0238010. PubMed ID: 33275613
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
[TBL] [Abstract][Full Text] [Related]
32. Rapid immunoprofiling of cytokines, chemokines and growth factors in patients with active rheumatoid arthritis using Luminex Multiple Analyte Profiling technology for precision medicine.
Bahlas S; Damiati L; Dandachi N; Sait H; Alsefri M; Pushparaj PN
Clin Exp Rheumatol; 2019; 37(1):112-119. PubMed ID: 29998825
[TBL] [Abstract][Full Text] [Related]
33. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
[TBL] [Abstract][Full Text] [Related]
34. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
Ribal MJ; Mengual L; Lozano JJ; Ingelmo-Torres M; Palou J; Rodríguez-Faba O; Witjes JA; Van der Heijden AG; Medina R; Conde JM; Marberger M; Schmidbauer J; Fernández PL; Alcaraz A
Eur J Cancer; 2016 Feb; 54():131-138. PubMed ID: 26761785
[TBL] [Abstract][Full Text] [Related]
35. Urinary protein biomarker panel for the detection of recurrent bladder cancer.
Rosser CJ; Chang M; Dai Y; Ross S; Mengual L; Alcaraz A; Goodison S
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1340-5. PubMed ID: 24714076
[TBL] [Abstract][Full Text] [Related]
36. Establishment of a bead-based duplex assay for the simultaneous quantitative detection of Neuropilin-1 and Neuropilin-2 using xMAP technology and its clinical application.
Huang ZL; Meng PP; Yang Y; Wang SY; Zhang XF; Luo FH; Yan JH; Wu T
J Clin Lab Anal; 2019 May; 33(4):e22850. PubMed ID: 30758083
[TBL] [Abstract][Full Text] [Related]
37. Comparison of pre-processing methods for multiplex bead-based immunoassays.
Rausch TK; Schillert A; Ziegler A; Lüking A; Zucht HD; Schulz-Knappe P
BMC Genomics; 2016 Aug; 17(1):601. PubMed ID: 27515389
[TBL] [Abstract][Full Text] [Related]
38. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.
Szarvas T; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky I; Rübben H
Hum Pathol; 2014 Apr; 45(4):674-82. PubMed ID: 24656090
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
40. Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms.
Bender DE; Schaettler MO; Sheehan KC; Johanns TM; Dunn GP
Biomark Insights; 2021; 16():11772719211006666. PubMed ID: 33854293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
